Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Advertising and marketing expense decreases 16.7% sequentially as revenue per dollar of advertising and marketing expense improves approximately 38%
Source
137 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Advertising and marketing expense decreases 16.7% sequentially as revenue per dollar of advertising and marketing expense improves approximately 38%
IntentKey’s Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds
GAAP Net Loss Narrows; Positive Adjusted EBITDA of $144,821 Reflects $516,000 Sequential Improvement
- Assets Under Management (“AuM”) Increased 5.0% Year-over-Year to $31.4 Billion -
Net Income of $3.2 Million, or $0.11 per Diluted Share, an $8.8 Million, or $0.42 per Diluted Share Increase Over Prior Year Quarter.
Secured debt reduced 94% and annual secured interest cut to approximately $138,000, with no Bitcoin pledged; mining margin improved to 50.7% from…
- FDA feedback expected in Q4 2026 on proposed use of new formulation of brilaroxazine in the RECOVER-2 trial and a future NDA submission -
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026
REVENUE GROWTH FOR FIRST QUARTER OF FISCAL 2027
Board Declares Quarterly Dividend of $0.25 per Share
Revenues and grant income of $66.3 million, compared to revenues and grant income of $30.4 million in 3Q 2025
Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results
•Net Sales for the third quarter 2026 were $19.1 million representing a 20% increase over the same period in 2025